Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
---|
09/04/2012 | CA2476581C Wheat detecting method |
09/04/2012 | CA2445370C Method of reducing analysis time of endpoint-type reaction profiles |
09/04/2012 | CA2432971C Polypeptides |
09/04/2012 | CA2351982C Selection and uses of lactic acid bacteria strains modulating non-specific immunity |
09/04/2012 | CA2295865C Method for diagnosing alzheimer disease |
08/30/2012 | WO2012116371A1 Methods and compositions for determining virus susceptibility to integrase inhibitors |
08/30/2012 | WO2012116294A1 Presence of erg gene rearrangements and protein over-expression in low grade pin (lg-pin) in prostate biopsies |
08/30/2012 | WO2012116289A2 Microbial signatures as indicators of radiation exposure |
08/30/2012 | WO2012116229A2 Compositions and methods for personal tumor profiling treatment |
08/30/2012 | WO2012116220A2 Materials and methods for detection of hpv nucleic acid |
08/30/2012 | WO2012116191A1 Rotation-dependent transcriptional sequencing systems and methods of using |
08/30/2012 | WO2012116146A1 Use of template switching for dna synthesis |
08/30/2012 | WO2012116122A2 A protein expression-based classifier for prediction of recurrence in adenocarcinoma |
08/30/2012 | WO2012116111A1 METHOD AND COMPOUNDS FOR GENERATION OF iPSCs |
08/30/2012 | WO2012116074A1 Biomarkers of insulin sensitivity |
08/30/2012 | WO2012115968A2 Methods of weed control involving aad-1 plants, and re-plant and/or pre-emergence herbicide applications |
08/30/2012 | WO2012115885A1 Circulating biomarkers |
08/30/2012 | WO2012115789A2 Recurrent spop mutations in prostate cancer |
08/30/2012 | WO2012115604A1 Mean dna copy number of chromosomal regions is of prognostic significance in cancer |
08/30/2012 | WO2012115493A2 Biomarker for cancer, and cancer diagnosis using same |
08/30/2012 | WO2012115464A2 Composition for hot-start pcr comprising blocking oligonucleotide |
08/30/2012 | WO2012115454A2 Method for concentrating cells that are genetically altered by nucleases |
08/30/2012 | WO2012115409A2 Method for using an enzyme resistant to high pressures |
08/30/2012 | WO2012115270A1 Method for selecting ips cell clone, and method for selecting gene used in method for selecting same |
08/30/2012 | WO2012115238A1 Method of visually determining site of origin of urine odor formation |
08/30/2012 | WO2012115153A1 Cell evaluation method, cell culture method, cell evaluation device, incubator, cell evaluation program, colony classification program, stem cell culture method, stem cell evaluation device, and stem cell evaluation program |
08/30/2012 | WO2012115068A1 Method of detecting mutant fgfr4 in breast cancer |
08/30/2012 | WO2012114312A2 Exogenous internal positive control |
08/30/2012 | WO2012114189A1 Method for predicting survival of glioblastoma patient using a ten-mirna signature |
08/30/2012 | WO2012114075A1 Method for processing maternal and fetal dna |
08/30/2012 | WO2012113965A1 Method for obtaining data that can be used to evaluate, predict and/or prognosticate response to treatment with pyrimidine analogues |
08/30/2012 | WO2012113954A1 Novel method for in vitro mutagenesis and cloning by means of reverse pcr for cloning |
08/30/2012 | WO2012113948A1 Method for determining genetic predisposition to parkinson's disease |
08/30/2012 | WO2012113819A1 Molecular biomarkers for predicting response to antitumor treatment in lung cancer |
08/30/2012 | WO2012113780A1 Method for quantifying human dna |
08/30/2012 | WO2012113773A1 Diagnosis of ischemia using sflt-1 and hgf after intervention as an early indicator of complication |
08/30/2012 | WO2012113760A1 Method of predicting the evolution of a patient suffering of stroke |
08/30/2012 | WO2012113699A1 Mass spectrometric determination of the inhibitory effect of substances on beta-lactamases |
08/30/2012 | WO2012113577A1 Method for quantifying human dna using an internal control |
08/30/2012 | WO2012113266A1 Antibody and antigen recognizing tumor-initiating cells and use thereof |
08/30/2012 | WO2012113072A1 A method for the selection of dna ligands for a molecular target |
08/30/2012 | WO2012113064A1 Method of diagnosing primary mediastinal b-cell lymphoma or classical hodgkin lymphoma by detecting functional mutation at ciita locus. |
08/30/2012 | WO2012113061A1 Cancer diagnosis and treatment |
08/30/2012 | WO2012096646A9 Direct detection of unamplified hepatitis c virus rna using unmodified gold nanoparticles |
08/30/2012 | WO2012094081A3 System and method for identifying and applying peripheral treatment mechanisms for disease |
08/30/2012 | WO2012073498A3 Sugarcane-stalk-sugar-content-related marker and the use thereof |
08/30/2012 | WO2012073495A3 Sugarcane-stalk-number-related marker and the use thereof |
08/30/2012 | WO2012073493A3 Sugarcane-sugar-yield-related marker and the use thereof |
08/30/2012 | WO2012057591A3 Resistance gene to xanthomonas axonopodis in soybeans |
08/30/2012 | WO2012050353A3 Method whereby the base sequence of a target polynucleotide is non-specifically extended |
08/30/2012 | WO2012049228A3 Marker sequences for multiple sclerosis and the use thereof |
08/30/2012 | WO2012048106A3 Biomarkers useful to predict mek inhibitor drug efficacy |
08/30/2012 | WO2012019175A8 Production of malonyl-coa derived products via anaerobic pathways |
08/30/2012 | WO2011091324A8 Methods of generating zinc finger nucleases having altered activity |
08/30/2012 | US20120222173 Plants with increased resistance to diabrotica virgifera and ostrinia nubilalis |
08/30/2012 | US20120222171 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
08/30/2012 | US20120222153 Aad-1 event das-40278-9, related transgenic corn lines, and event-specific identification thereof |
08/30/2012 | US20120222151 Disease resistant tomato plants |
08/30/2012 | US20120222141 Islet1 (isl1) and hearing loss |
08/30/2012 | US20120222139 Cancer Specific Mitotic Network |
08/30/2012 | US20120220751 Non-Fluorescent Quencher Compounds and Biomolecular Assays |
08/30/2012 | US20120220672 Presence of ERG Gene Rearrangements and Protein Over-expression in Low Grade PIN (LG-PIN) in Prostate Biopsies |
08/30/2012 | US20120220671 Use of galectin-3 for detecting and prognosing heart failure after acute coronary syndrome |
08/30/2012 | US20120220661 Methods of modulation of branched chain acids and uses thereof |
08/30/2012 | US20120220645 Genetic changes in atm and atr/chek1 as prognostic indicators in cancer |
08/30/2012 | US20120220610 Inhibitions of glutaminase c |
08/30/2012 | US20120220594 Methods for treating cancer in patients having igf-1r inhibitor resistance |
08/30/2012 | US20120220582 Imidazopyrazine syk inhibitors |
08/30/2012 | US20120220498 Fluorescence analyzing method, fluorescence analyzing apparatus and image detecting method |
08/30/2012 | US20120220495 Arrays of microparticles and methods of preparation thereof |
08/30/2012 | US20120220492 Viral Vectors with Improved Properties |
08/30/2012 | US20120220491 Retentate chromatography and protein chip arrays with applications in biology and medicine |
08/30/2012 | US20120220487 Determination of 17q Gain in Neuroblastoma Patients by Analysis of Circulating DNA |
08/30/2012 | US20120220485 Probe set and method for identifying hla allele |
08/30/2012 | US20120220483 Methods for fragmentation and labeling of nucleic acids |
08/30/2012 | US20120220479 Probes for specific analysis of nucleic acids |
08/30/2012 | US20120220477 Genetic markers associated with risk of diabetes mellitus |
08/30/2012 | US20120220474 Methods and compositions for diagnosis of thyroid conditions |
08/30/2012 | US20120220470 Diagnostic method for detecting cancer by measuring amount of a cytokine like il-6 |
08/30/2012 | US20120220469 Toxicity typing using liver stem cells |
08/30/2012 | US20120219985 Method for the toxicity assessments of nano-materials |
08/30/2012 | US20120219984 Method for the anaerobic treatment of a wastewater and associated device |
08/30/2012 | US20120219982 Methods for selecting active agents for cancer treatment |
08/30/2012 | US20120219981 Mechanical stretching device |
08/30/2012 | US20120219980 System and method for pipetting guidance |
08/30/2012 | US20120219978 Method and System for Detection of Chloramphenicol |
08/30/2012 | US20120219970 Methods for modulating macrophage proliferation in ocular disease using polyamine analogs |
08/30/2012 | US20120219965 Masp 2, a complement-fixing enzyme, and uses for it |
08/30/2012 | US20120219964 Bacterial atp synthase binding domain |
08/30/2012 | US20120219960 Methods using pores |
08/30/2012 | US20120219959 Targeted Chromosomal Mutagenesis Using Zinc Finger Nucleases |
08/30/2012 | US20120219958 MicroRNA Signatures Differentiating Uterine and Ovarian Papillary Serous Tumors |
08/30/2012 | US20120219957 Method of preparing a reaction mixture and related products |
08/30/2012 | US20120219956 Ngal for diagnosis of renal conditions |
08/30/2012 | US20120219954 Genotyping |
08/30/2012 | US20120219952 Carbapenemase and antibacterial treatment |
08/30/2012 | US20120219951 Probe, probe set, probe carrier, and testing method |
08/30/2012 | US20120219950 Assay systems for detection of aneuploidy and sex determination |
08/30/2012 | US20120219949 Method of detecting methylated dna in sample |
08/30/2012 | US20120219948 Application of quantum dots for nuclear staining |